Muscle Health and Prognosis in Patients With Cancer: New Insights
Journal of Cachexia, Sarcopenia and Muscle · 2026-06 · 17 (3)
DOI: 10.1002/jcsm.70292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 30.04.2026. Verfasst von Emanuele Cereda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Nutrition and Dietetics Unit, Fondazione IRCCS San Matteo, Pavia, Italy. Hauptthemen laut MEDLINE: Neoplasms, Muscle, Skeletal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione IRCCS Policlinico San Matteo, Abbott.
Abstract (Originalsprache)
Background
Reduced muscle mass and impaired composition have each been independently associated with worse outcomes in patients with cancer. However, emerging evidence suggests that reduced muscle strength—namely, dynapenia—may be particularly important for prognostication, as it is easier to assess in clinical practice compared to muscle mass. Importantly, muscle mass and composition—as assessed with computed tomography images—may not fully capture key physiological changes and/or reflect whole‐body alterations, particularly in patients who remain within the normal range. We investigated the predictive power for mortality of low muscle mass and impaired composition, weight loss (WL) and low strength, as well as their combination, in a cohort of patients with cancer.
Methods
Baseline data on muscle mass and radiodensity (Hounsfield units [HU]) at the L3 level—assessed using computed tomography—along with 6‐month unintentional WL (relevant if ≥ 10% of usual body weight) and muscle strength by handgrip were pooled for 477 patients with cancer (59.1% male, mean age 61.2 ± 12.8 years) from studies conducted in Brazil, Canada and Italy. Patients were categorized by sex and body mass index–specific cutoffs for low skeletal muscle mass index, low skeletal muscle radiodensity, WL ≥ 10% and low handgrip strength. Patients were followed for at least 12 months until death or censoring.
Results
During a median follow‐up of 43 months (IQR: 28–83), 188 patients died. Kaplan–Meier analysis showed no survival differences for low skeletal muscle index or low radiodensity, regardless of handgrip strength. Only WL ≥ 10% consistently identified patients with poorer prognosis, independently of low handgrip strength. Fully adjusted Cox's regression models showed an independent association only with WL (HR = 1.56 [95% CI: 1.12;2.16]; p = 0.008) and low handgrip strength (HR = 2.07 [95% CI: 1.47;2.92]; p < 0.001), as well as an increased risk for all low handgrip strength/%WL categories. Mortality risk increased across all low handgrip strength/%WL categories. Among the eight risk groups combining low skeletal muscle mass index, WL ≥ 10% and low handgrip strength, only those including WL ≥ 10% and low handgrip strength were significantly associated with higher mortality. Low skeletal muscle mass index contributed to a worse prognosis only when combined with both WL ≥ 10% and low handgrip strength. Similar results were observed when skeletal muscle radiodensity was used in replacement of skeletal muscle mass index.
Conclusions
In patients with cancer, muscle strength and WL were stronger survival predictors than muscle mass and composition, reinforcing their relevancy as easily assessed key markers of muscle health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Nutrition and Dietetics Unit, Fondazione IRCCS San Matteo, Pavia, Italy.
- Postgraduate Program in Nutrition and Food, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil.
- Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
- Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.
- Department of Clinical and Social Nutrition, Universidade Federal de Ouro Preto, Ouro Preto, Brazil.
- Department of Surgery, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
ORCID-Profile: Emanuele Cereda, Amanda Casirati, Maria Cristina Gonzalez, Nilian Carla Souza, Carla M Prado, Katherine L Ford, Silvia Fernandes Mauricio, Maria Isabel Toulson Davisson Correia, Paolo Pedrazzoli, Riccardo Caccialanza
Förderung
- Fondazione IRCCS Policlinico San Matteo
- Abbott
Zitieren
APA
Cereda, E., Casirati, A., Gonzalez, M. C., Souza, N. C., Prado, C. M., Ford, K. L., Mauricio, S. F., Correia, M. I. T. D., Pedrazzoli, P., & Caccialanza, R. (2026). Muscle Health and Prognosis in Patients With Cancer: New Insights. Journal of Cachexia, Sarcopenia and Muscle, 17(3). https://doi.org/10.1002/jcsm.70292
Vancouver
Cereda E, Casirati A, Gonzalez MC, Souza NC, Prado CM, Ford KL, et al. Muscle Health and Prognosis in Patients With Cancer: New Insights. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(3). doi:10.1002/jcsm.70292
BibTeX
@article{Cereda2026,
author = {Cereda, Emanuele and Casirati, Amanda and Gonzalez, Maria Cristina and Souza, Nilian Carla and Prado, Carla M and Ford, Katherine L and Mauricio, Silvia Fernandes and Correia, Maria Isabel Toulson Davisson and Pedrazzoli, Paolo and Caccialanza, Riccardo},
title = {Muscle Health and Prognosis in Patients With Cancer: New Insights},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2026},
volume = {17},
number = {3},
doi = {10.1002/jcsm.70292}
}
EUVIMED